Avastin highly efficacious for recurrent glioblastoma patientsAvastin, taken alone or as a combination therapy, is highly effective in terms of improved response rates, survival rates, and progression-free survival times in patients suffering from recurrent glioblastoma, which is a deadly form of brain cancer.

It was remarked by Dr. Timothy Cloughesy, director of the Neuro-Oncology Program at UCLA’s Jonsson Comprehensive Cancer Center and senior author of the study that a combination of Avastin and CPT-11 or Avastin alone has the ability to improve the response rate and overall survival to a significant extent.

It was further remarked by Cloughesy that the study findings can be termed as useful to treat patients with recurrent glioblastoma as Avastin is effective for reducing brain swelling and doses of steroids.